Affymetrix Inc. of Santa Clara won the race Thursday to market a single gene chip packed with fragments from each of the 35,000 known genes that make up the human genome. But two other Bay area ...

Affymetrix, a pioneering startup when it began independent operations in 1992, is still first in a DNA microarray market now estimated at $800 million in annual revenues.

Courtesy of Affymetrix Microarray giant Affymetrix has updated two of its more popular expression sets. With the release of the GeneChip® Mouse Expression Set 430 and Rat Expression Set 230, the ...

Affymetrix's GeneChip contains vital pieces of the 30,000 ... Some researchers even envision a day when pediatricians and other physicians are armed with these chips, technically called microarrays.

The ability to analyze and manipulate the human genome has taken an impressive step forward with the commercial launch on October 2 of a microarray for analysis of the whole genome on a single chip..

Affymetrix Inc. and Partners HealthCare have announced that they have entered into a three-year translational research collaboration to develop microarray-based diagnostics for complex diseases such ...

In addition, Affymetrix has become a member of InforSense’s Open Workflow Partner Network (OWPN) joining over 40 other partners in the program. The integration will enable scientists to analyze and ...

Ingenuity Systems and Affymetrix will be co-promoting Ingenuity® iReport™ with Affymetrix’ expression microarray products to help eliminate a bottleneck for researchers working with human ...